Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 38 filings·Updated 29 Sept 2026
Showing 10 of 38 filings.
29 Sept 20261 filing
AGM/EGMAGM

Transchem Ltd's 49th AGM approves financials, director re-appointment, and related party transactions via VC

AGM Details

  • Held on September 5, 2026 at 11:00 a.m. via VC/OAVM.
  • Remote e-voting window from September 1 to 4, 2026.

Resolutions & Outcomes

  • Adoption of Audited Financial Statements, Board's Report, and Auditors' Report; passed.
  • Re-appointment of director by rotation; passed.
  • Material related party transactions with Crest Ventures Limited; cap defined; passed.

Director Changes

  • Director re-appointed by rotation; term continues.

Auditors

  • Statutory auditors attended; no appointment changes disclosed.

Material Related Party Transactions

  • Approval for related party transactions with Crest Ventures Limited; cap defined per explanatory statement; approved.
Filed 14:35View Source
24 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Transchem Limited – Trading Window closed from Oct 01, 2026 until the end of 48 hours after declaration of the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026.

Transchem Limited – Trading Window closed from Oct 01, 2026 until the end of 48 hours after declaration of the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026.

Filed 15:55View Source
7 Sept 20261 filing
AGM/EGMAGM

Transchem Ltd's 49th AGM held Sept 5, 2026 via VC/OAVM approves audited financials, director re-appointment, and related party transaction

AGM Details

  • AGM held on September 5, 2026 at 11:00 IST via VC/OAVM
  • Record date: 29 August 2026; shareholders on record: 13,056
  • Attendees via VC: Promoter group 2; Public 62
  • All items transacted and passed by majority

Key Resolutions

  • Resolution 1: Adoption of Audited Financial Statements and Board/ Auditors' Report; ordinary; passed
  • Resolution 2: Re-appointment by rotation of Mr. Mahesh Suresh Rananavre; ordinary; passed
  • Resolution 3: Approval for material related party transaction with Crest Ventures Limited; ordinary; passed

Voting Results

  • All resolutions passed by requisite majority
  • RPT resolution: 304,358 shares polled, all in favour
Filed 17:46View Source
17 Aug 20261 filing
Company UpdateAcquisition

Transchem completes 100% acquisition of GSSL for INR 25.91 crore; GSSL becomes subsidiary

Transaction overview

  • Transchem Limited acquired 100% equity of Greshma Shares and Stocks Limited via SPA.
  • Acquisition completed on August 17, 2026; GSSL becomes a wholly-owned subsidiary.
  • Shareholding acquired: 1,55,16,000 equity shares representing 100%.
  • Consideration: INR 16.70 per share, totaling INR 25.91 crore, paid in cash.
  • GSSL becomes subsidiary of Transchem.

Target background

  • Greshma Shares and Stocks Limited is a public company incorporated on 12 August 2009 in Maharashtra.
  • Core activities: stock broking, capital markets, and financial services; NSE/BSE CM and CDSL DP.
  • Turnover INR 5.98 crore and net worth INR 21.32 crore as of 31 Mar 2026.
  • Presence in India with NSE/BSE trading and DP services.

Strategic rationale

  • Acquisition enables Transchem to enter financial services via GSSL platform.
  • Aims to broaden revenue base and enable future synergies.

Regulatory & timing

  • Pre-SPA approvals for change in control obtained from NSE, BSE, ICCL, CDSL, and SEBI.
  • Acquisition completion date: August 17, 2026.
  • Form of consideration: cash.
  • Price and share count: INR 16.70 per share for 1,55,16,000 shares.

Related party status

  • Promoter group of Transchem has no interest in GSSL; transaction not related party.
Filed 18:09View Source
12 Aug 20261 filing
Company UpdateNewspaper Publication

Please refer the attached intimation.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:44View Source
10 Aug 20263 filings
Company UpdateMonitoring Agency Report

Transchem's preferential issue proceeds remain unutilised; no deviation observed per MA report

Issue overview

  • Type: Preferential Issue; fully convertible equity share warrants.
  • Total size and proceeds: no revision or undersubscription noted.
  • Main objectives: strategic acquisition, technology development, regulatory capital, MTF deployment, GCP.

Utilisation of proceeds

  • Utilisation as disclosed: Yes; no changes observed in means of finance.
  • No utilisation in the reporting period; funds pending phased deployment.
  • Unutilised: 115.31 Cr; bank 75.31 Cr, liquid funds 15 Cr, fixed deposits 25 Cr.
  • Progress: none utilised; phased utilisation proposed in line with objects.
  • Approvals: Government approvals not required; no shareholder approvals noted.
  • GCP: 115 Cr allocated; utilisation pending; plan aligned with objects.

Governance and compliance

  • Statutory approvals not required for the objects.
  • No material events affecting viability reported.
  • No governance changes noted; deviation from objects: none observed.
  • Means of finance unchanged.
  • No regulatory or legal issues impacting objectives.

General Corporate Purpose (GCP)

  • GCP: 115 Cr allocated; utilisation pending; plan aligned with objects.
Filed 17:46View Source
Company UpdateGeneral

Transchem approves amended Code of Conduct for Insider Trading; Version 3.0 dated 10 Aug 2026

Purpose and approval

  • Board approved amendment to Transchem's Code of Conduct for Prevention of Insider Trading.
  • Approval occurred at the August 10, 2026 board meeting.
  • Amendment aligns with SEBI PIT Regulations, 2015, as amended.
  • Version 3.0 dated August 10, 2026; Annexure A attached.

Key contents and impact

  • Code governs connected persons and designated persons per SEBI PIT definitions.
  • Covers trading restrictions, UPSI handling, pre-clearance, and reporting requirements.
  • Annexures I–V outline pre-clearance, disclosures, confidentiality.
  • Compliance Officer role retained; annual and quarterly reporting to the Audit Committee.
Filed 17:39View Source
ResultFinancial Results

Transchem Ltd Q1 FY27 unaudited results: total income 511.36 L, net profit 342.11 L; warrants issued

Financial highlights

  • Unaudited Q1 FY27: total income 511.36 L; revenue from operations nil.
  • Other income 511.36 L; total income 511.36 L.
  • Net profit after tax 342.11 L; YoY growth from 99.33 L.
  • Basic EPS 2.79; diluted EPS 0.57.
  • Profit before tax 435.21 L; tax expense 93.10 L.
  • Current tax 81.87 L; deferred tax 11.23 L.
  • Total expenses 76.15 L; major items: employee benefits 26.86, depreciation 5.20, other expenses 43.25, finance cost 0.84.
  • No reportable segments; single operation.
  • Warrants issued: 61.5 million; upfront receipt 115.31 L.
  • Warrants exercisable; diluted EPS includes warrants impact.
  • Limited Review by Mathur & Co; no material misstatement observed.
  • Trading window reopens 48 hours after results.
  • Board meeting held Aug 10, 2026; 3:30–4:45 PM.
  • No segment reporting under Ind AS 108.

Insider trading & governance

  • Amendment to Code of Conduct for Prevention of Insider Trading approved.
  • Trading window restrictions and disclosure requirements outlined under SEBI PIT Regulations.
Filed 17:32View Source
8 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms no dematerialisation/rematerialisation requests; securities listed; ownership updated.

Dematerialisation/Rematerialisation status

  • No dematerialisation/rematerialisation requests were received during the period.
  • Securities dematerialised were listed on the exchanges where earlier securities are listed.
  • Physical certificates received for dematerialisation were mutilated and cancelled; depository registered owner substituted within prescribed timelines.
Filed 15:48View Source
29 May 20261 filing
Company UpdateReg.24(A)-Annual Secretarial Compliance

Please refer the attached intimation.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:30View Source
Showing 10 of 38 filings